Imperial is participating in Jisc’s ‘read and publish’ agreement with Bioscientifica from January 2021. This means that all corresponding authors affiliated with Imperial can publish in eligible journals open access without additional cost.

The agreement applies to all article types accepted for publication between 1 January 2021 and 31 December 2022 in the following hybrid journals:

• Journal of Endocrinology
• Journal of Molecular Endocrinology
• Endocrine-Related Cancer
• Reproduction

Please note that European Journal of Endocrinology is no longer part of this agreement and will transfer to Oxford University Press from 1st January 2023.

Bioscientifica will identify eligible authors by their institutional email address, so we advise you to use your Imperial email address when submitting your paper. If you are identified as eligible and select the open access option you should receive a 100% discount on the open access fee when checking out through Copyright Clearance Center's RightsLink service.

If you have any questions regarding this agreement or the process please contact the open access team.